Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8
- PMID: 2474813
Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8
Abstract
Isolated rat pancreatic acini were most sensitive and responsive when stimulated directly with cholecystokinin octapeptide (CCK-8) without preincubation. Both the responsiveness and sensitivity of acini to CCK-8 decreased time dependently with prolonged preincubation. When acini were stimulated with CCK-8 following pulse labeling with radioactive leucine, old protein was discharged together with newly synthesized (labeled) protein. However, the sensitivity and responsiveness of these acini for release of labeled protein were primarily reduced with preincubation, indicating that newly synthesized protein was contributing to the time-dependent loss of sensitivity and responsiveness. Then isolated acini were treated with 300 microM cycloheximide for 2 h. This treatment prevented the decreases in the sensitivity and responsiveness of amylase release to CCK-8 stimulation and made these alterations in one series of experiments negligible. Using these acini, a sensitive and specific bioassay for the measurement of CCK in human and rat plasma was developed.
Similar articles
-
CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.Pancreas. 1987;2(1):85-90. Pancreas. 1987. PMID: 2437574
-
A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.Am J Physiol. 1989 Oct;257(4 Pt 1):G594-600. doi: 10.1152/ajpgi.1989.257.4.G594. Am J Physiol. 1989. PMID: 2478032
-
Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.J Pharmacol Exp Ther. 1994 Feb;268(2):996-1002. J Pharmacol Exp Ther. 1994. PMID: 7509394
-
Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini.J Pharmacol Exp Ther. 1993 Feb;264(2):873-8. J Pharmacol Exp Ther. 1993. PMID: 7679738
-
Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.Gastroenterology. 1984 Sep;87(3):542-9. Gastroenterology. 1984. PMID: 6204904
Cited by
-
No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.Int J Pancreatol. 1995 Feb;17(1):29-35. doi: 10.1007/BF02788356. Int J Pancreatol. 1995. PMID: 8568332
-
Cholecystokinin and the hormone concept.Endocr Connect. 2021 Mar;10(3):R139-R150. doi: 10.1530/EC-21-0025. Endocr Connect. 2021. PMID: 33640870 Free PMC article. Review.
-
Role of endogenous bile on basal and postprandial CCK release in humans.Dig Dis Sci. 1993 Jul;38(7):1284-90. doi: 10.1007/BF01296080. Dig Dis Sci. 1993. PMID: 8391974
-
Relationship of plasma CCK to acinar cell regeneration in acute pancreatitis as studied by proliferating cell nuclear antigen.Dig Dis Sci. 1996 Sep;41(9):1828-37. doi: 10.1007/BF02088754. Dig Dis Sci. 1996. PMID: 8794803
-
Enhancement of biliary carcinogenesis in hamsters by cholecystokinin.World J Surg. 1995 Nov-Dec;19(6):847-50; discussion 850-1. doi: 10.1007/BF00299782. World J Surg. 1995. PMID: 8553677
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources